BOK Financial’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | – | Sell |
-159
| Closed | -$3.04K | – | 1283 |
|
2023
Q4 | $3.04K | Buy |
+159
| New | +$3.04K | ﹤0.01% | 1068 |
|
2023
Q3 | – | Sell |
-144
| Closed | -$3.34K | – | 1247 |
|
2023
Q2 | $3.34K | Hold |
144
| – | – | ﹤0.01% | 1002 |
|
2023
Q1 | $3.35K | Buy |
+144
| New | +$3.35K | ﹤0.01% | 1084 |
|
2015
Q3 | – | Sell |
-56,952
| Closed | -$1.94M | – | 868 |
|
2015
Q2 | $1.94M | Buy |
56,952
+2,249
| +4% | +$76.5K | 0.07% | 324 |
|
2015
Q1 | $1.94M | Buy |
54,703
+10,155
| +23% | +$359K | 0.07% | 324 |
|
2014
Q4 | $1.52M | Sell |
44,548
-15,789
| -26% | -$538K | 0.05% | 338 |
|
2014
Q3 | $2.33M | Sell |
60,337
-29,631
| -33% | -$1.14M | 0.08% | 278 |
|
2014
Q2 | $3.5M | Buy |
89,968
+8,991
| +11% | +$350K | 0.11% | 200 |
|
2014
Q1 | $2.77M | Buy |
80,977
+8,405
| +12% | +$287K | 0.09% | 237 |
|
2013
Q4 | $1.52M | Buy |
72,572
+21,096
| +41% | +$443K | 0.05% | 347 |
|
2013
Q3 | $1.21M | Buy |
51,476
+37,789
| +276% | +$888K | 0.04% | 380 |
|
2013
Q2 | $368K | Buy |
+13,687
| New | +$368K | 0.01% | 616 |
|